DE2111764A1 - Stabilisierte waessrige alpha-Aescin-Loesungen - Google Patents

Stabilisierte waessrige alpha-Aescin-Loesungen

Info

Publication number
DE2111764A1
DE2111764A1 DE19712111764 DE2111764A DE2111764A1 DE 2111764 A1 DE2111764 A1 DE 2111764A1 DE 19712111764 DE19712111764 DE 19712111764 DE 2111764 A DE2111764 A DE 2111764A DE 2111764 A1 DE2111764 A1 DE 2111764A1
Authority
DE
Germany
Prior art keywords
solutions
escin
propylene glycol
aescin
ethanol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19712111764
Other languages
German (de)
English (en)
Inventor
Dr Rer Nat Schlemmer Ferdinand
Klaus-Eberhard Dr Med Haase
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas Deutschland GmbH
Original Assignee
Klinge Pharma GmbH and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Klinge Pharma GmbH and Co filed Critical Klinge Pharma GmbH and Co
Priority to DE19712111764 priority Critical patent/DE2111764A1/de
Priority to AT150672A priority patent/AT314737B/de
Priority to NL7202683A priority patent/NL7202683A/xx
Priority to FR7207560A priority patent/FR2128621A1/fr
Priority to BE780411A priority patent/BE780411A/fr
Priority to LU64937D priority patent/LU64937A1/xx
Publication of DE2111764A1 publication Critical patent/DE2111764A1/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE19712111764 1971-03-11 1971-03-11 Stabilisierte waessrige alpha-Aescin-Loesungen Pending DE2111764A1 (de)

Priority Applications (6)

Application Number Priority Date Filing Date Title
DE19712111764 DE2111764A1 (de) 1971-03-11 1971-03-11 Stabilisierte waessrige alpha-Aescin-Loesungen
AT150672A AT314737B (de) 1971-03-11 1972-02-24 Verfahren zur Stabilisierung von wässerigen α-Aescinlösungen
NL7202683A NL7202683A (fr) 1971-03-11 1972-03-01
FR7207560A FR2128621A1 (en) 1971-03-11 1972-03-03 Injectable alpha-aescine solns - stabilised with alcohols
BE780411A BE780411A (fr) 1971-03-11 1972-03-09 Solutions aqueuses stabilisees de alpha-aescine
LU64937D LU64937A1 (fr) 1971-03-11 1972-03-09

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19712111764 DE2111764A1 (de) 1971-03-11 1971-03-11 Stabilisierte waessrige alpha-Aescin-Loesungen

Publications (1)

Publication Number Publication Date
DE2111764A1 true DE2111764A1 (de) 1972-09-21

Family

ID=5801248

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19712111764 Pending DE2111764A1 (de) 1971-03-11 1971-03-11 Stabilisierte waessrige alpha-Aescin-Loesungen

Country Status (6)

Country Link
AT (1) AT314737B (fr)
BE (1) BE780411A (fr)
DE (1) DE2111764A1 (fr)
FR (1) FR2128621A1 (fr)
LU (1) LU64937A1 (fr)
NL (1) NL7202683A (fr)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB754489A (en) * 1953-05-22 1956-08-08 Wellcome Found Injectable solutions of digoxin
FR1422009A (fr) * 1961-02-23 1965-12-24 Chem Fab Tempelhof Procédé de préparation d'extraits de marrons d'inde stables et contenant de la saponine
GB1106205A (en) * 1964-08-03 1968-03-13 Upjohn Co Improvements in or relating to pharmaceutical injectable suspensions

Also Published As

Publication number Publication date
AT314737B (de) 1974-04-25
FR2128621A1 (en) 1972-10-20
BE780411A (fr) 1972-09-11
FR2128621B1 (fr) 1975-06-13
LU64937A1 (fr) 1972-07-07
NL7202683A (fr) 1972-09-13

Similar Documents

Publication Publication Date Title
DE4344824C1 (de) Hochkonzentriertes Immunglobulin-Präparat und Verfahren zu seiner Herstellung
EP0117888A1 (fr) Compositions liquides de dihydropyridines, leur préparation et application thérapeutique
DE3027039A1 (de) Pharmazeutischer ansatz mit einer corticosteroid-substanz
DE2323187C2 (de) Verfahren zur Herstellung einer stabilisierten, pulverförmigen Secretinzubereitung
DE60125411T2 (de) Pharmazeutische dronedaron-zusammensetzung für die parenterale verabreichung
DE2734823C2 (de) Sonnenschutzmittel
DE3000743C2 (de) Arzneipräparat auf der Basis eines Salzes der Acetylsalicylsäure und einer basischen Aminosäure
DE2164052A1 (de) Kosmetische mittel mit nucleosidderivaten
DE3130912A1 (de) Analgetische arzneimittelkombination
DE1915798B2 (de) Antacidum-praeparat in form einer waessrigen suspension
EP0349797B1 (fr) Composition pharmaceutique stabilisée contenant de l'acétylcystéine
AT401469B (de) Pharmazeutische wässrige lösung zur parenteralen anwendung enthaltend einen in situ gebildeten komplex von einem alkaloid mit bis-indol-gerüst, sowie verfahren zu deren herstellung
CH680494A5 (fr)
EP1020192B1 (fr) Composition anti-cellulitique
DE2111764A1 (de) Stabilisierte waessrige alpha-Aescin-Loesungen
DE1252610B (de) Verfahren zum Stabilisieren von Katalase
DE2138586C2 (de) Injektionspräparat mit Vitamin A-Wirksamkeit
DE2930369A1 (de) Arzneimittelloesungen
CH400454A (de) Verfahren zur Herstellung von Lösungen des Chloramphenicols in wässrigen Flüssigkeiten
DE2314387C3 (de) Arzneimittel zur Behandlung bösartiger Neubildungen
DE1767666A1 (de) Arzneimittel mit stabilisierender Wirkung auf den Cytometabolismus
EP1309353B1 (fr) Solutions d'extraits de plantes contenant des flavones presentant une stabilite au stockage et a la chaleur amelioree
DE657129C (de) Verfahren zur Herstellung von Loesungen oder Extrakten aus Bakterien, Pollen oder sonstigen pflanzlichen Zellen
DE1792448B2 (de) Verfahren zur Herstellung von zur parenteralen Verabreichung geeigneten stabilen Lösungen von therapeutisch anwendbaren Benzodiazepinderivaten
DE714089C (de) Lichtschutzmittel